In 2011, those of us who prescribe selective serotonin reuptake inhibitors (SSRIs), received some shocking news. The United States Food and Drug Administration (FDA) issued a Drug Safety Communication (FDA, 2011) stating that citalopram can cause dose-dependent QT interval prolongation. And then more news from the FDA related to this topic followed in 2012 and 2013. What…